A simple yet multifaceted 90 years old, evergreen enzyme: Carbonic anhydrase, its inhibition and activation
CT Supuran - Bioorganic & Medicinal Chemistry Letters, 2023 - Elsevier
Advances in the carbonic anhydrase (CA, EC 4.2. 1.1) research over the last three decades
are presented, with an emphasis on the deciphering of the activation mechanism, the …
are presented, with an emphasis on the deciphering of the activation mechanism, the …
Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?
V Alterio, A Di Fiore, K D'Ambrosio, CT Supuran… - Chemical …, 2012 - ACS Publications
Carbonic anhydrases (CAs, EC 4.2. 1.1) are ubiquitous metallo-enzymes, present
throughout most living organisms and encoded by five evolutionarily unrelated gene …
throughout most living organisms and encoded by five evolutionarily unrelated gene …
Carbonic anhydrases: novel therapeutic applications for inhibitors and activators
CT Supuran - Nature reviews Drug discovery, 2008 - nature.com
Carbonic anhydrases (CAs), a group of ubiquitously expressed metalloenzymes, are
involved in numerous physiological and pathological processes, including …
involved in numerous physiological and pathological processes, including …
Carbonic anhydrase as a model for biophysical and physical-organic studies of proteins and protein− ligand binding
VM Krishnamurthy, GK Kaufman, AR Urbach… - Chemical …, 2008 - ACS Publications
Carbonic anhydrase (CA, EC 4.2. 1.1) is a protein that is especially well-suited to serve as a
model in many types of studies in biophysics, bioanalysis, the physical-organic chemistry of …
model in many types of studies in biophysics, bioanalysis, the physical-organic chemistry of …
[書籍][B] Carbonic anhydrase: its inhibitors and activators
CT Supuran, A Scozzafava, J Conway - 2004 - books.google.com
Carbonic Anhydrase: Its Inhibitors and Activators provides a state-of-the-art overview of the
latest developments and challenges in carbonic anhydrase research. Authors describe the …
latest developments and challenges in carbonic anhydrase research. Authors describe the …
Carbonic anhydrases as potential targets against neurovascular unit dysfunction in Alzheimer's disease and stroke
The Neurovascular Unit (NVU) is an important multicellular structure of the central nervous
system (CNS), which participates in the regulation of cerebral blood flow (CBF), delivery of …
system (CNS), which participates in the regulation of cerebral blood flow (CBF), delivery of …
Carbonic anhydrase activators
CT Supuran - Future medicinal chemistry, 2018 - Taylor & Francis
Mammalian carbonic anhydrases (CAs; EC 4.2. 1.1) of which 16 isoforms are known, are
involved in important physiological functions. Their inhibition is exploited pharmacologically …
involved in important physiological functions. Their inhibition is exploited pharmacologically …
Applications of carbonic anhydrase inhibitors and activators in therapy
Inhibitors and activators of the zinc enzyme carbonic anhydrase (CA, EC 4.2. 1.1) have a
large number of applications in therapy. Many types of such new derivatives have been …
large number of applications in therapy. Many types of such new derivatives have been …
Polyamines inhibit carbonic anhydrases by anchoring to the zinc-coordinated water molecule
F Carta, C Temperini, A Innocenti… - Journal of Medicinal …, 2010 - ACS Publications
Carbonic anhydrases (CAs, EC 4.2. 1.1) are inhibited by sulfonamides, phenols, and
coumarins. Polyamines such as spermine, spermidine, and many synthetic congeners are …
coumarins. Polyamines such as spermine, spermidine, and many synthetic congeners are …
Synthesis, molecular modeling, and biological evaluation of 4‐[5‐aryl‐3‐(thiophen‐2‐yl)‐4,5‐dihydro‐1H‐pyrazol‐1‐yl] benzenesulfonamides toward …
In this study, 4‐[5‐aryl‐3‐(thiophen‐2‐yl)‐4, 5‐dihydro‐1H‐pyrazol‐1‐yl]
benzenesulfonamides were synthesized, and inhibition effects on AC hE, hCA I, and hCA II …
benzenesulfonamides were synthesized, and inhibition effects on AC hE, hCA I, and hCA II …